PMC:7289100 / 40072-40328
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T485 | 229-237 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T486 | 229-233 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T487 | 240-249 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T162 | 93-97 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T245 | 0-256 | Sentence | denotes | The authors did not find any significant difference in terms of the rates of usage of either drug, thus they concluded that their findings raise doubts regarding the protective role of both these medication in the battle against SARS-CoV-2 infection [106]. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T542 | 93-97 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T543 | 229-239 | SP_7 | denotes | SARS-CoV-2 |
| T57559 | 93-97 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T27437 | 229-239 | SP_7 | denotes | SARS-CoV-2 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1373 | 229-249 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32535093-32194981-4828886 | 251-254 | 32194981 | denotes | 106 |